All Updates

All Updates

icon
Filter
Funding
Profluent raises USD 35 million in venture funding to accelerate company’s growth
AI Drug Discovery
Mar 21, 2024
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Mar 21, 2024

Profluent raises USD 35 million in venture funding to accelerate company’s growth

Funding

  • AI-based protein engineering company Profluent has secured an additional USD 35 million in its latest venture funding round led by Spark Capital, with participation from existing investors Insight Partners and Air Street Capital and angel investors. This follows the company's USD 9 million seed round in August 2022, bringing the total funding raised to USD 44 million.

  • The funds will be utilized to accelerate the company’s next growth phase, which includes enhancing proprietary LLMs and datasets, expanding the wet laboratory capabilities, and improving the efficiency of CRISPR gene-editing systems. 

  • Founded in 2022, Profluent leverages GenAI models to learn the genetic code's language to design and validate new, functional proteins to advance in biomedicine. The company's primary aim is to design novel, functional proteins that address existing industry limitations. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.